Genixus Introduces New Propofol RTA Syringe

Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, will offer Propofol as the first product within its KinetiX platform of RTA syringe products at the Annual National Pharmacy Purchasing Association Conference (Booth...

Cohen Children’s Medical Center Unveils $110M Pediatric Surgical Operating Complex

Cohen Children’s Medical Center has announced the opening of the Pediatric Surgical Operating Complex, a $110 million, 24,000-square-foot, state-of-the-art home for pediatric surgery that greatly enhances the capabilities of New York State’s No. 1 provider of...

AAAHC Calls for 2022-23 Bernard A. Kershner Innovations in Quality Improvement Award Submissions

Today, the Accreditation Association for Ambulatory Health Care (AAAHC) opens submissions for the 2022-23 Bernard A. Kershner Innovations in Quality Improvement (QI) Awards. Named in honor of the late Bernard A. Kershner, a leader in ambulatory health care and...

Movano Ring Company Eyes FDA Submission

Movano Inc., a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the successful completion of a study with the University of California San Francisco (UCSF) to assess the accuracy of the Movano Ring’s...

Surfacide Earns High Marks in KLAS Research Report

In a newly released report from KLAS Research, a health care research firm, Surfacide UV Technology has received all “A” ratings for its Helios UV-C System. The report’s performance insights include product satisfaction, customer support, value, loyalty, culture and operations.

A sampling of organizations using Surfacide technology were surveyed, including large and small hospital health systems, academic health systems, standalone hospitals and clinics. Of those surveyed, top reasons for selecting Surfacide as their UV-C of choice were the patented triple emitter UV-C light technology, vendor support and technology/laser mapping features.

According to a press release, some notable insights and top key performance indicators include:

  • “A” rating across the board for overall customer satisfaction
  • “A+” when it comes to recommending Surfacide Helios System
  • 100% indicate they would purchase again.
  • Achieves desired disinfection outcomes
  • Improves patient experience and satisfaction noted through HCAHPS scores
  • High level of customer support drives customer satisfaction

“The KLAS report findings of straight A’s across the board are an honor and further validate what Surfacide clients have been saying for years,” said Gunner Lyslo, founder and CEO of Surfacide. “Our customers and the facilities we serve consistently receive best-in-class products, vendor support and results that improve lives and truly make an impact in the healthcare industry and beyond.”



Submit a Comment

Your email address will not be published.